KYTHERA BIOPHARMACEUTICALS INC (KYTH) [Rocket]

In millions, except per share items	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09
	10-K	10-K	10-K	10-K	10-K/A	S-1/A
Product sales, net	132.4	50.5	19.7	13.0	4.5	29.5
Product sales, net growth	162.3%	156.4%	51.6%	189.3%	-84.8%
Operating expenses:
Cost of sales			1.9	1.2	0.4	14.8
In-process research and development	52.8
Research and development	47.8	34.0	43.2	15.8	14.8
Selling, general and administrative	31.1	16.1	10.5	6.9	6.8
Total operating expenses	264.0	100.5	107.8	45.6	43.4
Loss from operations	-131.7	-50.1	-35.9	-10.8	-17.6
Operating margin	-99.4%	-99.2%	-182.5%	-83.5%	-391.0%
Interest income	0.3	0.1
Interest expense	-4.2	-2.0	-0.4	-0.1
Net loss	-135.6	-51.9	-36.8	-11.2	-16.0

Other comprehensive income (loss):
Comprehensive loss	-135.7	-51.9	-36.8	-11.2	-16.0

Per share information:
Net loss, basic and diluted (in dollars per share)	($6.04)	($2.71)	($7.47)	($7.98)	($11.64)

Basic and diluted weighted average shares outstanding (in shares)	22.5	19.2	4.9	1.4	1.4